A girl's baffling symptoms led her scientist parents to ChatGPT as they searched for answers to her medical mystery.

The AI due-diligence startup is relocating its CEO to Boston as U.S. revenue hits 50% of its total business.

The Colorado quantum firm gets government cash and gives up nearly 2.4 million shares in return.

A Toronto-bound MIT planetary scientist and a Harvard microbiome expert headline Canada's biggest academic poaching wave yet.

Tim Andrews of Barrington, NH says he's doing well after becoming the first patient to move from a pig kidney to a human one.

Historic Boston Archives turns real old photos into AI clips full of driverless cars and misspelled signs. Followers aren't buying it.

The 10,000-square-foot space swaps a windowless 1960s theater for a 40-foot glass hall overlooking the Charles River.

DURAVYU missed its main goal against Regeneron's Eylea, but the company says a small subgroup of unrelated vision loss skewed the results.

Suffolk, Wentworth, Northeastern and Endicott are rolling out AI-infused degrees, but a Suffolk petition against the plan drew 1,200 signatures in two days.

About 23 jobs are gone as Aura Biosciences narrows its focus to a single eye cancer drug and stretches cash into 2029.

LifeMine Therapeutics just banked $263 million for a kidney-friendly transplant drug — a comeback for a scientist whose first startup nearly went nowhere.

Boston’s Liquid AI is betting a leaner model architecture can challenge OpenAI and Anthropic. A $250 million AMD-led round is helping fund the fight.

Analog Devices disclosed unauthorized access to company systems after files were stolen. The Wilmington chipmaker has not said what data was taken or whether customers were affected.